What happened
The U.S. Supreme Court on Friday agreed to hear four cases, including a Monsanto Co. dispute over whether federal pesticide law preempts certain failure-to-warn claims.
The order granted review in Hikma Pharmaceuticals v. Amarin Pharma, Monsanto Co. v. Durnell, Chatrie v. United States and Anderson v. Intel Corp. Investment Policy Committee. The short order did not state votes, note separate opinions or set out a merits schedule.
For Monsanto, the court limited the grant to whether the Federal Insecticide, Fungicide, and Rodenticide Act preempts a label-based failure-to-warn claim when EPA has not required the warning. That issue gives the justices a vehicle to address the relationship between federal pesticide labeling oversight and state-law warning claims.
For Chatrie, the court limited review to Question 1 presented by the petition, but the order itself does not state that question. The order likewise does not describe the issues in Hikma or Anderson beyond granting certiorari.
The grants signal new merits cases for the court’s docket, but the order-list excerpt alone does not supply the lower-court history, party arguments or legal reasoning needed for a fuller analysis. The next reporting step is to review the petitions and underlying decisions to identify the precise questions and stakes in each case.